Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oliphenol was a private U.S. nutraceutical company focused on extracting and commercializing olive polyphenols from organic olive pulp and related by-products. Its core commercial product was HIDROX, an olive-derived polyphenol ingredient rich in hydroxytyrosol, marketed for supplements, functional foods, cosmetics, and wellness applications. The company also pursued regulatory and ingredient commercialization work, including an FDA GRAS notice for hydrolyzed aqueous olive pulp extract for food use. Publicly available materials describe interests in immunity, longevity, skin health, antiviral applications, and neurodegenerative wellness research, but not a conventional drug-development pipeline. Available databases indicate the company was private and later marked closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oliphenol.